Literature DB >> 23680961

Relation of angiographic side branch calibre to myocardial mass: a proof of concept myocardial infarct index.

Ghassan S Kassab1, Deepak L Bhatt, Thierry Lefèvre, Yves Louvard.   

Abstract

Elevation of biomarkers and ischaemia after coronary stenting of a bifurcation is not uncommon due to side branch (SB) occlusion. Hence, it is important to understand the relation between the lumen calibre of the SB and the myocardial mass affected. The objective of this proof of concept perspective is to provide a formulation for the relation between the SB calibre and perfused myocardial mass based on experimentally-validated scaling laws. A lumen calibre-mass scaling law provides a nearly linear relation between cross-sectional area of SB and the myocardial mass at risk. It is clinically known that the larger the diameter of the SB the more myocardial mass is at risk. The present analysis formulates this notion quantitatively and provides a simple relation where the %infarct can be determined directly from the angiographic cross-sectional area of SB. This relation can help guide the decision for bifurcation stenting where the SB may be at risk for occlusion. This brief proof of concept perspective provides a basis for future human studies that may demarcate the calibre (and hence myocardial mass) in relation to cardiac biomarkers as a cut-off for treatment of SB.

Entities:  

Mesh:

Year:  2013        PMID: 23680961     DOI: 10.4244/EIJV8I12A220

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

1.  The Need For Dedicated Bifurcation Stents: A Critical Analysis.

Authors:  Maciej Lesiak
Journal:  Interv Cardiol       Date:  2016-10

2.  Bifurcation functional significance score as predictor of mortality: a validating study.

Authors:  Dobrin Vassilev; Niya Mileva; Carlos Collet; Pavel Nikolov; Katerina Sokolova; Kiril Karamfiloff; Vladimir Naunov; Jeroen Sonck; Gianluca Rigatelli; Ghassan S Kassab; Robert J Gil
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.